Glenmark Pharmaceuticals Limited
GLENMARK.BO
Price:
$1965.75
Market Cap:
$555.43B
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, Japan, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes ISB 2001, a BCMA x CD38 x CD3 trispecific antibody, which is in Phase 1 clinical trial for oncology; GRC 39815, a retinoid-related orphan receptor gamma t inverse agonist, which is in Phase 1 clinical trial for the treatment of chronic obstructive pulmonary disease; and GRC 54276, a hematopoietic p...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-02-10
Stock Exchange
BSE
Ticker
GLENMARK.BO
PE Ratio
[54.94]
ROE
[8.72%]
Current Ratio
[0]
Dividend Yield
[0.25%]
Enterprise Value
[555.43B]
Dividend History
GLENMARK.BO Dividend History Overview
Dividends are a key part of long-term returns for investors, and Glenmark Pharmaceuticals Limited (GLENMARK.BO) has a track record worth reviewing. Looking at dividend history for GLENMARK.BO gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2025-10-03
Dividend Yield
0.25%
Annual Dividend
$2.50
P/E Ratio
54.94
Payout Ratio
0
Dividend per Share
$5.00
EPS
35.78
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2025-10-03 | $2.5 | $2.5 | 2025-10-26 | |
| 2025-09-15 | $2.5 | $2.5 | 2025-10-01 | |
| 2024-09-13 | $2.5 | $2.5 | 2024-10-27 | |
| 2023-09-18 | $2.5 | $2.5 | 2023-10-29 | |
| 2022-09-12 | $2.5 | $2.5 | 2022-10-27 | |
| 2021-09-08 | $2.5 | $2.5 | 2021-10-24 | |
| 2020-09-17 | $2.5 | $2.5 | 2020-10-29 | |
| 2019-09-19 | $2 | $2 | 2019-10-27 | |
| 2018-09-19 | $2 | $2 | 2018-10-28 | |
| 2017-09-20 | $2 | $2 | 2017-10-29 | |
| 2016-08-03 | $2 | $2 |
Glenmark Pharmaceuticals Limited (GLENMARK.BO) Dividend History Chart
The table below shows Glenmark Pharmaceuticals Limited (GLENMARK.BO) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Glenmark Pharmaceuticals Limited (GLENMARK.BO) Dividend Growth
Glenmark Pharmaceuticals Limited (GLENMARK.BO) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Glenmark Pharmaceuticals Limited (GLENMARK.BO) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is GLENMARK.BO’s dividend yield?
What is the difference between regular and special dividends?
Has GLENMARK.BO increased its dividends over time?
Why might dividend history data be delayed?
How often does GLENMARK.BO pay dividends?
What factors impact GLENMARK.BO's dividend payments?
Can dividends change over time?
What is GLENMARK.BO’s next dividend date?